PKD1 and polycystic kidney disease: In polycystic kidney disease, SLC9B2 is significantly upregulated and positively correlated with cyst size, regulated by the polycystin-1/Ca2+/NFAT signaling axis, which can be induced by vasopressin and methylxanthine drugs (63).